From the intersection of the TCGA tumor types with homeobox genes, hypermethylation of CERS2 was identified as a biomarker for the cholangiocarcinoma (CHOL) dataset, functioning as a tumor suppressor49,50. The gene discussed is CERS2; the disease is cholangiocarcinoma.